Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)

NCT01263769 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: Axitinib

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]